Morerecent GWA studies have shown that genetic variation(SNPs) in ANRIL are associated with a wide variety ofmetabolic and immune-mediated diseases such as CAD,however, little is known regarding its molecular role inthe pathology of these diseases (9, 10). This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.